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INTRODUCTION
Our definition of a percutaneous implant is an object foreign to the
body placed through the skin such that a permanent defect is created. The
concept has been described in the past for many purposes, but not until
the last 20 years have investigators been able to keep a device implanted
without rejection and/or infection. The applications of such a device
include hemodialysis (Stryker, et al., 1971), power supply (Miller,
et. al., 1971), charging for cardiac pacemakers (Rogers, et al., 1967),
and neuroelectric stimulation of nerves and/or muscles (Mooney and
Hartmann, 1974; Mooney, Hartmann, McNeal and Benson, 1974). Also
included in this is recording with clear signals from nerves
(Kadefors, et al., 1970), skeletal attachment of artificial limbs
(Mooney, et al., 1971), and dental implants (Grenoble, et al., 1973).
The problems created by having a percutaneous device present are mainly
those of low grade and/or deep infection with ultimate rejection of the
implant. In our experience at Rancho Los Amigos Hospital since 1968,
using primarily percutaneous pure carbon, we have found that if
proper care is taken, most infections will heal without need of implant
removal. This proper care is protection from repeated minor trauma
and local antibiotics if inflammation or drainage starts.
There are two main hemostatic mechanisms by which an implant may remain
free of deep infection. One mechanism is a'discharge of squamous
epithelial cells from the down-growing of the epithelium layer extruding
+	 outward along the neck of the implant. This cellular debris carrywith
" them the bacteria and other contaminating elements out from the deep
layers. A second mechanism is an enclosing wall of synovial type
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tissue lining the entire implant, sealing it from the
layers. However, this second mechanism seems to be rr
to minor trauma, the implant is less well anchored tc
may eventuate in the expulsion of the device in a "pc
button-hole manner.
DES1Gi: AND MATERIALS
The initial design was a silastic device with a centE
Figure 1.	 Early implant design,
silastic with a carbon center.
This implant was similar to the ones used by Nelson (1969) and
Stryker (1971).	 The implant was used for chronic dialyj-is patients
with the carbon center acting as an interface. The subcutaneous
3
iportion of this was a dacron skirt sewn and glued into the silastic
to allow for tissue ingrowth and fixation.
The difficulties with this type of implant arose from the failure to
find a good method of bonding the silastic to the carbon ring. Many
epoxies were tried, but all of them eventually broke down and allowed
fluids to leak externally, thus creating a passageway for an infection
to penetrate internally. Moreover, the object was too large for
practical use and the skin-implant interface would not heal well. The
size of the implant did not allow it to move freely with the supple
skin. Thus, the skin would pull away from the implant, allowing for
further leakage, irritation, and possibly infection.
Our next experience was with an all pure carbon design, both low
temperature isotrophic (LTI) and vitreous carbon (VC). We experimented
with several different types of shapes and sizes. The early "daisy"
design did not allow good tissue ingrowth as we had hoped. In addition,
it did not have a neck tall enough, so it would tend to sink below
the level of the skin which would epithelialize over it.
In the next generation of devices a satisfactory design was attained.
This device has a flange in which are spaced numerous holes. Initially
the holes were both of too small a diameter and too great a depth to
allow for adequate vascularization of the ingrowing tissue. The latest
<	 designs incorporate large holes of similar design which has alleviated
this problem (Fig. 2 on page 5).
A further advance was made in materials utilizing both unpolished and
polished LTI carbon. A major difference with the titanium (TI) devices
4 9
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Figure 2. Succeeding designs; from the left, early "daisy"
shape, polished carbon with permanent connector, Titanium
with pin connector, polished carbon with magnetic connector.
is that they have a polished surface.	 Grenoble, et al., (1973)
evaluating dental implants, found that the tissue seemed to affix
better to unpolished surfaces which he felt afforded a better implant
fixation.
To evaluate whether a polished surface would actually make a significant
percutaneous device, three volunteers at Rancho Los Amigos Hospital
agreed to have six buttons implanted in their anterior thighs. Three
titanium and three different type carbon buttons were implanted for
a 12-week duration. The devices were removed in-mass with a tissue
block so that the interface could be microscopically studied with-
out any difficulty.
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Prior to removal, India Ink was held by a thi ,ale-type apparatus over
the implant for 15 minutes. On removal, (Fig. 3) shows the under-
sur`ece and the excellent tissue ingrowth through the 2.8 mm. holes.
Following 24 hours, the tissue was sharply dissected from the implant
around most of the buttons. In the buttons that had some infection
or leakage there was not a tight seal.	 It can be seen in (Fig. 4) that
the India Ink penetrates the deeper layers, intermixing with the red
blood cells in the areas of the synovial lining around the surface of
the button.
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Figure 4. Microscopic view showing India Ink penetration into
the synovial lining.
On histological examiniatior, we found no difference between any of the
buttons, either titanium or carbon. They all had a similar number of
reactive cells, a similar amount of inflammation, no outright rejection,
and all seemed to be well seated into the subcutaneous tissue. This,
we felt that polished TI could easily be utilized for the devices along
with carbon.
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PERCUTANEOUS ELECTRICAL CONNECTORS (BUTTONS)
Design
The percutaneous buttons we are presently using are of two materials-
low temperature isotrophic (LTI) l and titanium (TI) 2 and are both of
the same design and dimensions. There are three different neck sizes
to accommodate the different skin depths at various anatomical sites.
For example, for use in a fatty area, one needs a longer neck to insure
that it will not be buried under the subcutaneous tissue. The dimensions
for the neck heights are 1.8 mm., 3 mm., and 4.4 mm. The diameter
of the base is 15 mm. and there are eight holes of 2.8 mm. diameter
in the flange. This 2.8 mm. diameter was found to be satisfactory
for tissue growth.
Connector Systems
An additional problem we had, aside from device design and materials,
was an effective connector system. Our earlier generation permanent
corrector would catch on clothes, etc., leading to an eventual infection
with drainage around the base of the device. The advances made in
developing a simple, less traumatic connector have recently been
described by Mooney, et al., (1976).
Briefly, a magnet is mounted in the head of the device as well as the
external lead. The lead is self-centering when brought in close
proximity to the device. This design allows an easy disconnect if
there is a sudden force pulling on the lead, avoiding irritation at
the skin-implant interface. Figure _5 as seen on page 9 is a device
z
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1. General Atomic Company, La Jolla, California.
2. Medtronic, Inc., Minneapolis, Minnesota.
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Figure 5. Percutaneous button with magnetic connector in place.
that has been implanted for eight weeks, and has undergone six weeks
of repeated connection/disconnection up to 40 times a day without
serious trauma or problems. Currently, development is underway on a
bipolar magnetic connector.
Types
There are four different types of electrodes, depending on the type of
conduction and stimulation that is needed. Type I is used when just
the presence of electrode at the skin surface is needed. It has
generalized distribution of current and is primarily used in the clinical
9
rapplication for chronic pain relief, using one of the transcutaneous
nerve stimulators currently available. Before the patient has these
buttons implanted, he uses surface electrodes to determine the site
for stimulation. ThL: electrode connective devices are implanted for
convenience sake. We have had a number of patients who have had
these implanted in place for one or two years with minimal problems,
mainly related to the connector systems.
Type II is for more direct application of current and allows for greater
tolerance of high current densities. It is insulated except for the
bottom portion, protecting the cutaneous aspect from stimulation and
irritation. Thus, the patient can tolerate more current for motor
point stimulation. The button is placed over the motor point that
has been predetermined by surface stimulation. Its primary use is
for stimulation of muscles that are either weak from disuse atrophy,
e.g., postoperative atrophy, or weak secondary to spinal cord injury
or stroke. In addition, these are used in a stimulation program
combined with surgical release for contracture correction (Mooney, et al., 1976).
The third button, Type III (Fig. 6 as seen on page 11), is one with
a wire electrode leading from the button down to a nerve or muscle
for implantation. The entire button is insulated except for the tip
of the wire. This button is for exact motor or sensory stimulation,
thereby avoiding a diffuse stimulus. In addition, it can be applied
for recording nerve action potentials. It is also an important component
in a sensory feedback system for upper extremity prostheses_ The lead
wire is a teflon coated wire attached to a 30-gauge needle, the last
centimeter bare for contact. The needle is passed through the epinerium_
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Figure 6. Left - Type III percutaneous electrode with intra-
neural wir electrode. Right - Modified Type III with carbon
probe in place of the intraneural tip.
of the nerve for approximately 11-13 mm. distance and then out so the
needle can be cut off leaving the bare wire for stimulation (Fig. 7 page l?.).
We have shown on experiments of cat nerves that this does not disrupt
the nerve sheaths and does not cause any irritation or malfunction of
the nerve.
The Type IV button is one with a larger bipolar lead terminating with
a wrap-around electrode which is sutured around the nerve. This has
been used in a program for contracture correction using peripheral
mor ,)Y' nerve stimulation.
It
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Figure 7. Schematic drawing of an intraneural electrode.
The ap p roximately 1 cm length of coiled wire inside the
nerve is deinsUldted.
Implantation Technique
Implantation of non-wire connected devices can be done in the office or
out-patient operating room in about ten minutes per implant (Fig. 8).
area.	 The site should be in an anatomically convenient area away from j
aF
joints which allow too much skin motion.	 A small amount of local
anesthesia, e.g., xylocaine, is injected into the site where the j
implant is to be placed. 	 A 2 cm.	 incision is then undermined for
approximately a 1-1/2 cm. space to the side of the incision. 	 A biopsy-
type hole-punch is then used to make the hole through which the
button will be pushed. 	 The punch size is 5 mm. diameter and made over
the area undermined. 	 Then, using a sizing button (similar to the ones
implanted permanently), which has a neck with three neck sizes
defined, it is determined which size neck is appropriate in that area.
Once the correct implant is chosen, it is slipped similarly through
-	 the incision and brought through the punch hole. 	 The incision is
then closed with interrupted non-absorbable sutures and an antibiotic
ointment is placed on the wound, which is then dressed with a simple
gauze dressing.
Post-implantation care is similar to any other small incision. Sutures
are usually removed in ten days to two weeks, although we do not
start any stimulation via the implants for at least two weeks to
allow time for the tissue to stabilize.
Cl inical Application
At Rancho Los Amigos Hospital, we have implanted over 125 percutaneous
electrode devices, with a total of over 965 implant-months experience.
As stated above in the description of the various types, , our clinical
applications presently include chronic pain relief, contracture
correction, and sensory feedback. Results indicate an overall success
rate of 60% with the separate breakdownof results described in
4
	
	
Tables 1-3.
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No. Buttons
Pain Relief	 36
Contracture Correction 	 58
Sensory Feedback	 9
Volunteer (no stimulation) 	 24
TOTAL	 127
14
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TABLE I
TOTAL	 MATERIAL
Type I	 73	 Vitreous Carbon	 49
Type II	 32	 Low Temperature Isotrophic	 41
Type III	 11	 Titanium	 37
Type IV	 11
	
127	 127
TABLE II
CATEGORIES FOR PERCUTANLOUS ELECTRODES
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Sensory Feedback for Prostheses
3
It is generally recognized that the success of functional sub- 	
p
stitution and the rate of successful patient fitting is far better
for lower limb prostheses than upper limb devices. Certainly the
function of grasp and release is more difficult to replace and control
than the swing and stance phases of lower limb prosthetic function.
But perhaps a more devastating loss in the upper limb amputee is
the absence of sensation which provides the normal hand with the
feedbakc necessary for manual dexterity. The purpose of this project
was not only to provide the amputee with a powered myoelectrically
controlled prosthesis, but also to provide substitute sensory feed- 	 j
back through the peripheral nervous system.
Since this study was conceived to identify the applicability of
neuroelectric feedback systems to the upper limb amputee using
myoelectric controlled and electronically powered prostheses, it
was decided to challenge the question of applicability to various
type of amputee problems.
Three different types of amputees were studied. The first
amputee was already an experienced and truly functional user of a
7
cable driven below-elbow prosthesis. 	 He was tested to objectively
identify the amount of non-visual feedback of terminal device position
that are inherent in a functional user.	 This amputee was used
to verify the technical feasibility of the transcutaneous
t
neuroelectric feedback system. The second amputee fit with the
SA
system was a recent below-elbow amputee who had not yet become expert
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in the use of any prosthesis. He was fit with the VA-NU powered
prosthesis, with the neuroelectric feedback system. He was also fit
with a standard prosthesis for comparison. The third subject was a
recent bilateral below-elbow amputee who had the neuroelectric feed.-
back system applied to the non-dominant limb (left) and specific
comparisons concerning the use and function of the two prostheses were
made.
The first patient could find no advantage to the feedback, as he was
accustomed to wearing conventional prostheses for eight years. On
this basis he asked to he discontinued from the study and the Type III
carbon buttons were removed under local anesthesia in the clinic.
The second patient (R.H.) was fit ;;ith a myoelectric hand, but
Figure 10. Patient A.G. without prostheses and with the
cable driven prostheses. The prosthesis on his left is
equipped with the feedback system, which passes signals to
his nerves via percutaneous carbon buttons.
17
I^	 i	 I	 I	 I
interference between the electric controls and the sensory feedback
system caused continuous malfunctions, despite an extensive amount
of filtering and redesign work. Other problems, which may not have
been related to the implants caused this patient to reject the
sensory feedback system.
The third patient (A.G.) was a success (Fig. 10 on page 11). 	 He was
right handed but is presently left hand dominant due to his preference
for the feedback system, which he has been using. He states it "Gives
me the sensation that the prosthesis is part of me." Extensive
testing has shown that the patient's ability to differentiate sizes of
objects held in the hook is far better with the feedback system (Fig. 11).
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Figure 12.	 Conceptual illustration of the sensory feedback
system applied to a powered, myoelectrically controlled prosthesis.
Currently, information on both position and force are presented
by electrical stimulation of the ulnar nerve (Fig. 12). A single
electrode 2 mil. in diameter of helically coiled stainless-steel
wire is buried in the nerve. A one centimeter length is deinsulated
and threaded through the nerve at the time of surgery. An indifferent,
or ground, electrode is also implanted.
When the hook or hand is closed with no object between the two fingers,
no signal is applied to the nerve. When the hook is opened slightly,
19
ia train of electrical pulses are transmitted into the nerve by way of
the intraneural electrode. As the hook opens further, the repetition
of frequency increases, reaching a maximum of 80 pulses per second
at maximum opening (four inches).
The current design providds not only position feedback but also
force feedback. When the patient grasps a hard object, such as a
wooden block, and applies a force through the terminal device, the
pulse duration increases linearly with force. The transducers for
position and force are specially constructed and mounted on the hook.
PROSTHETIC SUSPENSION VIA SKELETAL IMPLANT
An additional use of carbon has been as a transcutaneous interface for
skeletal attachment of a prosthesis in amputees. At the present state
of our art in prosthetics, the high above-elbow amputee possesses a
particular problem with regard to suspension and prosthesis control.
Conventional means of suspension consist of shoulder harnessess and
straps, both of which are cumbersome and acosmetic. The short
residual limb often has too limited a lever arm for effective control
of the prosthetic limb.
Our present design was developed with the cooperation of the National
Aeronautics and Space Administration and Dr. Jack Bokros of General
Atomic Company. It consists of a stainless steel with carbon collar
implant that is cemented with methylmethacrylate to the intramedul'lary
canal of the bone in the amputee's stump (Fig. 13 on page 21, 14 on page 22).
The implant is then brought through the skin with the unpolished carbon
collar as an interface._ Suspension of a prosthesis is now achieved
'i	
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Figure 13.
	
Intramedullary skeletal fixation device.	 Stainless-
less steel rod with a carbon collar.
via a quick disconnect device that locks into the shaft of the implant.
Initially designed for the below-knee amputee, it was found that the
trauma with even simple ambulation was enough to prevent maintenance
of a good seal at the skin-interface, resulting in leakage and/or
infection.
Presently, the skeletal iriplant is
amputee, avoiding the conventional
carbon/stainless steel implant has
B( ause the patients were failures
conventional system, we had hoped
acceptable. Post-operatively, the
delayed secondary to a superficial
being applied to the a'.
suspension system. To
been utilized in three
with regard to fitting
the new device would be
patients' new fittings
wound infection, which
)ove-elbow
,ate, the
amputees.
by the
more
were
at the
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Figure 14. Skeletal prosthesis attainment unit
implanted in leg of amputee.
time of discharge was controlled with local skin care. Unfortunately,
all implants have required removal in less than six months post-
implantation secondary to chronic infection aggravated by mechanical
irritation. At present, further evaluation is necessary to determine
the efficacy of the device for human amputee use.
DISCUSSION
Our experience with chronic: percutaneous passage is summarized in
Table 4 on page 23. The first criteria for successful percutaneous
22
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passage is that the material be biocompatible. As Table III suggests,
our greatest experience has been with vitreous carbon, and with
this material we have also had out most significant success. Lesser
success is noted with LTI carbon and even slightly less with Titanium.
These discrepancies are not statistically significant, but our
clinical impression remains that vitreous carbon has apparently unique
characteristics from the standpoint of tissue compatibility.
Our experience has taught us, however that the major problem is not
TABLE 4
CRITERIA FOR ELECTRODE IMPLANTATION
1. Biocompatible material.
2. Device not fixed to deep tissue.
3. Mobility to move with skin.
4. Insert only in area of normal tissue.
5. Insert in best anatomical area.
6. Keep as flush to skin as possible.
at the level of biocompatibility, but rather mechanical forces. If
the device cannot move with the skin itself, the stress concentrations
at the skin—implant interface become excessive and gradually an inflammatory
reaction results. In fact, the majority of our failures must be on
account of excessive mechanical activity rather than any problems
related to bacterial flora, allergic reaction, etc.
We have found that healthy skin tolerates this intrusion quite well. If
left free of excessive mechanical stresses, the implant can exist 	
3
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through the skin with a minimum of special attention. Washing twice
daily is sufficient in those patients whose hygienic habits are normal.
However, where the skin is poorly vascularized or where the implant
will frequently abut against skeletal prominences, failure is likely.
Finally, the implant must not protrude through the skin to such a
level that it will easily catch upon objects. Many of our earlier
failures were due to the electrical mechanical connector wherein the
wire "tether" attached to the implant would not release with sufficient
ease so that constant tugging occurred at the interface. With the
new electro-magnetic connector; our success rate has been higher.
One might look upon this work as merely demonstrating that the body
can "encapsulate" the foreign material if this material is sufficiently
non-irritating. This indeed may be an adequate summary. Certainly
we have had no evidence that the body will extrude the implants. Nor
have we had any evidence that proliferating cellular material in the
depth of the implant will form granulomata and clusters of cells.
Epithelial desquamation only occurs at the neck of the implant and
has not been demonstrated to occur in a deeper area.
We think this work does demonstrate that an adequate bacterial seal
can be achieved for a prolonged period of time at the human skin-
implant interface. This experience hopefully will encourage others
to try alternative approaches in order to compare experience.
SUMMARY
Experience with 127 percutaneous implants in 43 patients and volunteers
has been presented. A prolonged success of these implants can be
24
1expected if mechanical factors are reduced to a minimum. At this
point, there is insufficient statistical data to indicate which of
three biocompatible materials is ideal, but pure carbon has demonstrated
the highest level of success.
I	 i	 I 	 I!	 I	 I
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